TFA Therapeutics (RAJAF) Current Leases (2020 - 2025)

TFA Therapeutics has reported Current Leases for 6 years, with the latest figure at $13173.0 in Q4 2025.

• On a quarterly basis, Current Leases fell 84.86% year-over-year to $13173.0 in Q4 2025; TTM through Dec 2025 was $13173.0, a 84.86% decrease from a year earlier, with the FY2025 full-year figure at $13173.0, down 84.86% from the prior year.
• Current Leases was $13173.0 for Q4 2025 at TFA Therapeutics, down from $87016.0 in the prior quarter.
• The five-year high for Current Leases was $99055.0 in Q3 2023, with the low at $13173.0 in Q4 2025.
• Average Current Leases over 5 years is $68780.2, with a median of $76626.5 recorded in 2021.
• The sharpest annual moves came in 2021 and 2025: Current Leases surged 1309.6% in 2021, then tumbled 84.86% in 2025.
• Over 5 years, Current Leases stood at $66237.0 in 2021, then dropped by 13.78% to $57109.0 in 2022, then soared by 57.75% to $90091.0 in 2023, then declined by 3.41% to $87016.0 in 2024, then sank by 84.86% to $13173.0 in 2025.
• The last three Current Leases figures came in at $13173.0 (Q4 2025), $87016.0 (Q4 2024), and $90091.0 (Q4 2023), per Business Quant data.